Saltar a Buscador
Saltar a menú servicios
Saltar a Noticias y Convocatorias - Menú principal. Secciones - - Fin de Menú principal -
The Importance of Genoma España’s Activities
- Summary of Genoma España's 2009 Activities
- Evolution of Genoma España's Resources (2002-2009)
- Evolution of Genoma España's Expenditure (2003-2009)
- Performance Indicators (PDF) - available only in Spanish
- Report on Genoma España's 2009 Activities (PDF) - available only in Spanish
Summary of Genoma España's 2009 Activities
As the result of the overall activities carried out by Genoma España 218 jobs have been created. Since 2004, Genoma España has contributed to the creation of 90 biotechnology-based companies 87 of which were still active as of 31 December 2009.
During 2009, 18 companies have been created with the annual average increase of 15-16 companies, which implies the creation of a company for every 1.5 to 1.6 Genoma España employees.
Jobs Created (*)
|
Funded by
Genoma España (1)
|
Funded by other
Institutions (2)
|
Total | |
| Genoma España (3) | 25 | - | 25 |
| R&D Projects | 64 | 117 | 181 |
| Science and Technology Platforms | 101 | 59 | 160 |
| Technology Portfolio | 24 | 16 | 40 |
| Bioentrepreneurs | 4 | 12 | 16 |
| Total | 218 | 204 | 422 |
(*) University grads and PhDs per year
(1) Jobs directly created and funded by Genoma España
(2) Positions directly provided by private/public institutions
(3) Genoma España staff
During 2009, Genoma España's mission and objectives have changed. The Foundation focuses on technology and innovation transfer activities. R&D projects and S&T platforms will be no longer supported by Genoma España. Instead, for example, the latter will be managed by the Carlos III Health Institute. Nevertheless, the InnoCash programme will be managed and technology transfer activities will be increased.
Evolution of Genoma España's Resources (2002-2009)
The 2009 governmental-decrees regarding shoestring budget cuts have reduced in 50% the ministerial contributions to Genoma España from 11M € to 4.9 M €. For 2010 only 6 million euros is forecasted. Taking into account that 5.3M € provided by the ministry for science and innovation by way of the FECYT go to the InnoCash programme, contributions recover the value of 10.2M €.
Our revenue mainly comes from: public-private R&D projects; monetary contributions made by the private sector members of our board of trustees, funds recovered by our financial unit and the commercialization of our technology portfolio. Since no future RFA will be launched our revenues decrease to 2.43M€.
.gif)
The mobilized funds contribute resources to our R&D projects, to the S&T platforms (8.47M € in 2009) and to our current technology portfolio.
However, considering that the 2009 InnoCash programme resources have been much greater since the ministry for science and innovation has provided 6 million euros out of which 5.3M € were awarded to Innocash projects, these projects have mobilized 18.3M € from external resources. In addition, Genoma España has collaborated with the FECYT in the promotion and award of the RFA for project valorization experts. In total, mobilized funds have reached 18.33 M € in 2009. For every euro that the Ministry has contributed the Foundation has mobilized 2.8 €.
Evolution of Genoma España's Expenditure (2003-2009)
Genoma España's management model based on the promotion and implementation of our activities using public-private funding has been consolidated. The general costs of Genoma España have been between 3% and 4% and that of personnel between 7% and 8%. Thus, 90% of our funds have been dedicated to financing the cost of our overall activities.
Genoma España's Expenditure from 2003 to 2009
|
Year |
General Costs |
Personnel Costs |
Costs for Activities |
Total |
||||
|
Euros* |
Percent |
Euros* |
Percent |
Euros* |
Percent |
Euros* |
Percent |
|
|
2003 |
824 |
8% |
767 |
8% |
8.187 |
84% |
9.778 |
100% |
|
2004 |
506 |
4% |
820 |
7% |
10.198 |
88% |
11.524 |
100% |
|
2005 |
554 |
4% |
893 |
6% |
12.486 |
90% |
13.933 |
100% |
|
2006 |
397 |
3% |
1.040 |
8% |
12.150 |
89% |
13.587 |
100% |
|
2007 |
472 |
3% |
1.159 |
8% |
12.365 |
88% |
13.996 |
100% |
|
2008 |
465 |
3% |
1.197 |
7% |
16.378 |
91% |
18.040 |
100% |
|
2009 |
571 |
6% |
1.301 |
14% |
7.448 |
80% |
9.320 |
100% |
|
2009 + Innocash |
571 |
4% |
1.301 |
9% |
12.710 |
87% |
14.582 |
100% |
(*) Thousands of Euros
Throughout 2009 there have been four board of trustees meetings in which Genoma España's 2010-2013 strategic plan and 2010 action plan have been approved.
Genoma España has successfully been audited by the State General Comptroller and has received the ISO9000 Quality Certification in 2010.
